Literature DB >> 9679746

Sero-epidemiologic and phylogenetic studies of HTLV-I infection in 2 countries of the Caspian Sea region.

N Senyuta1, A Syrtsev, M Yamashita, V Stepina, O Susova, L Scherbak, O Pavlish, M Hayami, V Gurtsevitch.   

Abstract

Phylogenetic analysis of HTLV-I variants persisting among population of Turkmenistan and the Republic of Georgia (situated on both sides of the Caspian Sea, not far from a known HTLV-I cluster in Northern Iran) has been carried out. HTLV-I isolates from the above countries were obtained in the course of seroepidemiological investigations. In all, 1,510 blood-donor samples from Turkmenistan and 47 blood samples from hematological patients from Georgia, were tested with different screening and confirmatory assays, including commercial ones. As a result, 7 infected individuals (3 blood donors and 4 relatives of one blood donor) from Turkmenistan and 3 infected individuals (one ATL patient and 2 of his relatives) from Georgia were found. In addition, 4 HTLV-I isolates from Turkmenistan and one from Georgia were cloned and part of their LTR was sequenced. Phylogenetic analysis of sequenced isolates allowed us to conclude that these isolates belonged to sub-type A, one of 3 sub-types of the "Cosmopolitan" type. We found that most of the Turkmenian isolates formed a tight cluster and shared common nucleotide substitutions with isolates originating from Northern Iran (Mashhad). The data obtained suggest that there is a new endemic focus of HTLV-I infection in the Caspian Sea region. Further investigations are required to confirm this hypothesis.

Entities:  

Mesh:

Year:  1998        PMID: 9679746     DOI: 10.1002/(sici)1097-0215(19980812)77:4<488::aid-ijc2>3.0.co;2-q

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

Review 1.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

2.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

3.  Seroepidemiology of human T-cell lymphotropic virus type-I in blood donors of Northeastern Iran, Sabzevar.

Authors:  Mahtab Maghsudlu; Hamidreza Safabakhsh; Parastoo Jamili
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

4.  Seroepidemiology of HTLV-1 and HTLV-2 Infection in Neyshabur City, North-Eastern Iran, during 2010-2014.

Authors:  Mohammad Salehi; Seyyed Khalil Shokouhi Mostafavi; Abdolmajid Ghasemian; Mahmoud Gholami; Abdolrahim Kazemi-Vardanjani; Mohammad Karim Rahimi
Journal:  Iran Biomed J       Date:  2016-07-05

5.  Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.

Authors:  Gharib Karimi; Maryam Zadsar; Ali Akbar Pourfathollah
Journal:  Virol J       Date:  2017-01-30       Impact factor: 4.099

6.  Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel.

Authors:  Shmuel Stienlauf; Vered Yahalom; Eli Schwartz; Eilat Shinar; Gad Segal; Yechezkel Sidi
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

Review 7.  A Systematic Review for Estimation of HTLV-I Infection in the Blood Donors of Iran.

Authors:  Mohammad Reza Hedayati-Moghaddam
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

8.  Seroepidemiology of human T-cell lymphotropic virus type-1 (HTLV1) in Mashhad.

Authors:  Hamidreza Safabakhsh; Mehrdad Jalalian; Gharib Karimi
Journal:  Glob J Health Sci       Date:  2014-05-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.